Although ADA-SCID was the first inherited disorder successfully treated with gene therapy [9], the hematopoietic stem cell transplantation (HSCT) remains the only potentially curative treatment for SCID to date, regardless of the underlying molecular defect. Here, ADA is linked to severe combined immunodeficiency.